In the quest to revolutionize medicine, our bodies are becoming living laboratories. By 2030, it’s estimated that bioprinting could address up to 20% of the organ transplant waiting list globally. These groundbreaking technologies are set to generate custom, patient-specific organs – potentially saving thousands of lives each year. As we transition into an era of on-demand, tailored organ creation, critical questions emerge.

Join us for a conversation with Dr. Mark Skylar-Scott, a pioneering researcher in bioprinting technology, and Assistant Professor of Bioengineering at Stanford University, on how bioprinting could transform the landscape of organ transplantation and potential consequences for healthcare and equitable access.

Hosted by: Alexa Raad and Leslie Daigle.

Further reading:

• 
  
• Moonshot effort aims to bioprint a human heart and implant it in a pig
  
  
• Gurdon and Yamanaka share Nobel prize for stem cell work
  
  
• ARPA-H bets $26 million that the time has come for 3D printed organs
  

The views and opinions expressed in this program are our own and may not reflect the views or positions of our employers.